Stocktoria
Arcus Biosciences, Inc. RCUS
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2018-03-15
Chart by TradingView
0/9
Piotroski F — financial health
-0.75
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $33.0M | $258.0M | $117.0M | $38.0M | $383.0M |
| Operating income | -$386.0M | -$330.0M | -$340.0M | -$280.0M | $54.0M |
| Net income | -$353.0M | -$283.0M | -$307.0M | -$267.0M | $53.0M |
| Operating cash flow | -$482.0M | -$170.0M | -$306.0M | $438.0M | -$256.0M |
| Free cash flow | -$484.0M | -$176.0M | -$330.0M | $432.0M | -$282.0M |
| Total assets | $1.1B | $1.1B | $1.1B | $1.3B | $1.6B |
| Total liabilities | — | — | — | — | $750.4M |
| Shareholders' equity | $631.0M | $485.0M | $462.0M | $657.0M | $842.0M |
| Ratios | |||||
| Operating margin | -1169.7% | -127.9% | -290.6% | -736.8% | 14.1% |
| Net margin | -1069.7% | -109.7% | -262.4% | -702.6% | 13.8% |
| FCF margin | -1466.7% | -68.2% | -282.1% | 1136.8% | -73.6% |
| Return on assets | -31.0% | -24.6% | -28.0% | -19.9% | 3.3% |
| Return on equity | -55.9% | -58.4% | -66.5% | -40.6% | 6.3% |
| Debt / equity | 0.16× | 0.10× | 0.00× | — | — |
| Current ratio | 4.36 | 4.50 | 4.52 | 5.53 | 7.60 |
| Revenue growth | -87.2% | 120.5% | 207.9% | -90.1% | 391.0% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 424,700 | $9.2M |
| Point72 Asset Management, L.P. | 129,273 | $2.8M |
Why these scores methodology →
Piotroski F-score: 0/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -0.75 (distress)
- Working capital / assets 0.681
- Retained earnings / assets -1.304
- EBIT / assets -0.339
- Equity / liabilities 1.242
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001724521 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.